Antineutrophil cytoplasmic antibodies in scleroderma patients: First report of a case with anti-proteinase 3 antibodies and review of the literature

Revue du Rhumatisme (Edition Francaise)

Volumn 69, Issue 3, 2002, Pages 265-269

  Caramaschi, Paola ^a,b   Biasi, Domenico ^a   Tonolli, Elisabetta ^a   Carletto, Antonio ^a   Bambara, Lisa Maria ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Policlinico GB Rossi   (Italy)

Author keywords

Antineutrophil cytoplasmic antibodies (ANCA); Scleroderma

Indexed keywords

ENZYME ANTIBODY; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PROTEIN ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INCIDENCE; KIDNEY DISEASE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; SCLERODERMA; SCREENING TEST; SKIN MANIFESTATION; SYSTEMIC SCLEROSIS;

EID: 0036205756     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(02)00284-3     Document Type: Article

References (31)

1. Autoantibodies against neutrophils and monocytes: Tool for diagnosis and marker of disease activity in Wegener's granulomatosis
2. Clinical course of anti-neutrophil cytoplasmic auto-antibody-associated glomerulonephritis and systemic vasculitis
3. Antineutrophil cytoplasmic antibodies
4. Autoantibodies to myeloperoxidase in systemic sclerosis
5. Antineutrophil cytoplasmic antibodies in 6 patients with renal failure and systemic sclerosis
6. Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis
7. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis
8. Anti-neutrophil cytoplasmic antibodies in 566 European patients with systemic lupus erythematosus: Prevalence, clinical associations and correlation with other autoantibodies
9. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features
10. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus
11. Anti-neutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus
12. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance
13. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus
14. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus in childhood
15. Antineutrophil cytoplasmic antibodies in primary Sjögren's syndrome: Prevalence and clinical significance
16. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: A marker of severe disease with associated nephropathy
17. Incidence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis
18. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis patients
19. Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: An early marker of progressive erosive disease
20. Antineutrophil cytoplasm antibodies (ANCA) in rheumatoid arthritis: Relationship to HLA-DR phenotypes, rheumatoid factor, anti-nuclear antibodies and disease severity
21. Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: A prospective study
22. Antineutrophil cytoplasmic autoantibody-associated diseases: A rheumatologist's perspective
23. Normotensive renal failure in a patient with systemic sclerosis and p-antineutrophil cytoplasmic antibodies which developed into Paget's disease of bone after immunosuppressive therapy
24. MPO-ANCA-positive crescentic glomerulonephritis: A distinct entity of scleroderma renal disease?
25. Myeloperoxidase-specific anti-neutrophil cytoplasmic antibodies-related scleroderma renal crisis treated with double-filtration plasmapheresis
26. Systemic sclerosis and antineutrophil cytoplasmic autoantibody-associated renal failure
27. Limited cutaneous systemic sclerosis associated with MPO-ANCA positive renal small vessel vasculitis of the microscopic polyangiitis type
28. D-penicillamine-induced crescentic glomerulonephritis and antimyeloperoxidase antibodies in a patient with scleroderma. Case report and review of the literature
29. Antineutrophil cytoplasmic antibodies in systemic sclerosis with renal failure
30. Diffuse alveolar hemorrhage in limited cutaneous systemic sclerosis with positive perinuclear antineutrophil cytoplasmic antibodies
31. Long-term outcome in mixed connective tissue disease: Longitudinal clinical and serologic findings